You are the owner of this page.
Edit Page
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Corbus Pharma (NQ: CRBP)
5.130 USD  +0.180 (+3.64%)
Official Closing Price  /  Updated: 5:55 PM EST, Dec 6, 2019  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 504,000
Open 4.970
Bid (Size) 4.960 (3)
Ask (Size) 5.250 (3)
Prev. Close 4.950
Today's Range 4.910 - 5.150
52wk Range 4.180 - 9.110
Shares Outstanding 57,142,496
Dividend Yield N/A
Performance
YTD
-21.68%
-21.68%
1 Month
+4.69%
+4.69%
3 Month
-5.87%
-5.87%
6 Month
-24.78%
-24.78%
1 Year
-22.97%
-22.97%
Top News
More News
Corbus Pharmaceuticals Completes Enrollment of Phase 2b Study of Lenabasum for Treatment of Cystic Fibrosis
from GlobeNewswire News Releases
Corbus Pharmaceuticals to Present at the Jefferies 2019 Global Healthcare Conference in London
from GlobeNewswire News Releases
More News
Read More
Corbus Pharmaceuticals Updates Data from Lenabasum Open-Label Extension Studies in Systemic Sclerosis and Dermatomyositis at 2019 ACR Annual Meeting
from GlobeNewswire News Releases
Corbus Pharmaceuticals Reports 2019 Third Quarter Financial Results and Provides Clinical and Corporate Updates
from GlobeNewswire News Releases
Corbus Pharmaceuticals to Host Conference Call and Webcast to Discuss Third Quarter 2019 Operational and Financial Results on November 7, 2019
from GlobeNewswire News Releases
Interesting CRBP Put And Call Options For July 2020
category Stocks
from Market News Video
Analysts Predict 17% Upside For VTWG
category ETFs
from ETF Channel
Add Up The Parts: IBB Could Be Worth $139
category ETFs
from ETF Channel
Is Corbus Pharmaceuticals Stock a Buy?
category Market News , CRBP
from Motley Fool
Better Buy: GW Pharmaceuticals vs. Corbus Pharmaceuticals
category Market News , CRBP , GWPH
from Motley Fool
Here’s how investors should think about the FDA’s warning on CBD
category LHSIF , SMG , GTBIF , and 19 more.
from MarketWatch
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.